Low-dose urokinase thrombolytic therapy for patients with acute intermediate-high-risk pulmonary embolism: A retrospective cohort study

INTRODUCTION: Patients at intermediate-high risk of developing a pulmonary embolism (PE) are very likely to experience adverse outcomes, such as cardiovascular instability and death. The role of thrombolytic therapy in intermediate-high-risk PE remains controversial. OBJECTIVES: This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Cuilian, Wang, Xincai, Huang, Long, Lin, Xingsheng, Liu, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997002/
https://www.ncbi.nlm.nih.gov/pubmed/33770113
http://dx.doi.org/10.1371/journal.pone.0248603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997002/
https://www.ncbi.nlm.nih.gov/pubmed/33770113
http://dx.doi.org/10.1371/journal.pone.0248603

Ejemplares similares